Related Experiment Video

Updated: Oct 3, 2026

A Cre-Lox P Recombination Approach for the Detection of Cell Fusion In Vivo
08:13

A Cre-Lox P Recombination Approach for the Detection of Cell Fusion In Vivo

Published on: January 4, 2012

Application of Cre-loxP system to the urinary tract and cancer gene therapy

I Yoshimura1, S Suzuki, M Hayakawa

  • 1Department of Urology, National Defense Medical College, Tokorozawa, Saitama, Japan. ichiro-y@me.ndmc.ac.jp

Molecular Urology
|November 3, 2001
PubMed

Insights

The Cre-loxP system enables precise DNA recombination for gene targeting. This versatile tool allows conditional gene knockout and promoter enhancement for research and potential gene therapy applications.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • The Cre-loxP system, derived from bacteriophage P1, is a key tool in molecular biology.
  • It facilitates in vivo DNA recombination, crucial for genetic manipulation.
  • Its versatility makes it indispensable for advanced gene targeting research.

Purpose of the Study:

  • To highlight the utility of the Cre-loxP system in genetic research.
  • To demonstrate its application in conditional gene knockout strategies.
  • To explore its potential in enhancing promoter activity for therapeutic purposes.

Main Methods:

  • Utilizing the Cre-loxP recombination system for targeted DNA modifications.
  • Combining Cre-loxP with specific promoters for conditional gene expression control.
  • Applying the system to achieve gene deletion in specific tissues or developmental stages.

Main Results:

  • Successful conditional knockout of target genes in specific cell types.
  • Enabling the deletion of essential genes in adult animals, bypassing embryonic lethality.
  • Demonstrating enhanced tissue- or tumor-specific promoter activities.

Conclusions:

  • The Cre-loxP system is a powerful and adaptable tool for in vivo DNA recombination.
  • Its applications range from fundamental gene targeting to potential gene therapy strategies.
  • The system's simplicity and effectiveness suggest broad future research utilization.

More Related Videos

An Orthotopic Bladder Cancer Model for Gene Delivery Studies07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Ex Vivo Organoid Model of Adenovirus-Cre Mediated Gene Deletions in Mouse Urothelial Cells09:16

Ex Vivo Organoid Model of Adenovirus-Cre Mediated Gene Deletions in Mouse Urothelial Cells

Published on: May 5, 2022

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...